DACIA OAKESON: Open Payments
NPI 1013271246 · HASTINGS, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$8,451 in 54 payments from 10 companies in 2025. Trend: 2023 $15,954 · 2024 $5,895 · 2025 $8,451
Speaker / faculty: $7,500Food & beverage: $658Travel & lodging: $293
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 36 | $8,095 |
| Otsuka America Pharmaceutical, Inc. | 5 | $97 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $72 |
| PFIZER INC. | 3 | $48 |
| ABIOMED | 1 | $35 |
| Exact Sciences Corporation | 2 | $32 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
Products named: VRAYLAR, REXULTI, UBRELVY, CAPLYTA, Cologuard Collection Kit, NURTEC ODT, ABILIFY MAINTENA, Auvelity.
Industry payments across NE — which companies pay providers there.
